These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23614051)

  • 1. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
    van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
    Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single-center study.
    Song L; Zhai X; Yu S; Ma Y; Wang F; Yu X; Tao S; Lian Y; Yang M; Tao W; Fan Q
    Cancer Med; 2019 Jul; 8(8):3729-3737. PubMed ID: 31127690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study.
    Chi Y; Liu S; Zhang J; Li H; Yang L; Zhang X; Li H; Li Q; Wang N; Lu M; Zhuo M
    BMC Public Health; 2024 May; 24(1):1396. PubMed ID: 38789981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and management of malignant digestive endocrine tumours in a well defined French population.
    Lepage C; Bouvier AM; Phelip JM; Hatem C; Vernet C; Faivre J
    Gut; 2004 Apr; 53(4):549-53. PubMed ID: 15016750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approach.
    Chien LH; Tseng TJ; Chen CH; Jiang HF; Tsai FY; Liu TW; Hsiung CA; Chang IS
    Cancer Med; 2017 Jul; 6(7):1762-1775. PubMed ID: 28560749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological profile of neuroendocrine tumors in adults in Brazil.
    Brunelli Pujatti P; Paim V; Gonçalves R; Vilhena B; Bergmann A; Santos Thuler LC; Bulzico D
    Arch Endocrinol Metab; 2024 May; 68():e230013. PubMed ID: 38709149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and Age-Period-Cohort Effect on Incidence of Male Breast Cancer from 1980 to 2019 in Taiwan and the USA.
    Peng JY; Lee YK; Pham RQ; Shen XH; Chen IH; Chen YC; Fan HS
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of quality of clinical management of neuroendocrine tumors.
    Bloemen H; Kneepkens K; Deraedt K; Ivanova A; Sergeant G; Mebis J; Van der Speeten K
    Cancer Innov; 2022 Dec; 1(4):305-315. PubMed ID: 38089084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Lung Cancer Survival to the Future: Population-Based Cancer Survival Modeling Study.
    Meng FT; Jhuang JR; Peng YT; Chiang CJ; Yang YW; Huang CY; Huang KP; Lee WC
    JMIR Public Health Surveill; 2024 May; 10():e46737. PubMed ID: 38819904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charting the Course: Insights into Neuroendocrine Tumor Dynamics in the United States.
    Wu C; Song Z; Balachandra S; Dream S; Chen H; Rose JB; Bhatia S; Gillis A
    Ann Surg; 2024 May; ():. PubMed ID: 38708616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma Incidence in Taiwan Over a Recent 20-Year Period: A Comprehensive Nationwide Study.
    Lin HY; Ho CH; Lin YS; Kuo SC; Chen YC; Cheng YJ
    Int J Gen Med; 2024; 17():909-917. PubMed ID: 38476628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
    Lim CH; Lee IS; Jun BY; Kim JS; Cho YK; Park JM; Roh SY; Lee MA; Kim SW; Choi MG
    Korean J Intern Med; 2017 May; 32(3):452-458. PubMed ID: 28490723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
    Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
    Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
    Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
    JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
    Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
    J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china.
    Fan JH; Zhang YQ; Shi SS; Chen YJ; Yuan XH; Jiang LM; Wang SM; Ma L; He YT; Feng CY; Sun XB; Liu Q; Deloso K; Chi Y; Qiao YL
    Oncotarget; 2017 Sep; 8(42):71699-71708. PubMed ID: 29069739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
    Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric neuroendocrine neoplasms.
    Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
    Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
    Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.